Rituximab and Acalabrutinib in Newly Diagnosed B Cell Post Transplant Lymphoproliferative Disorder
Condition: Post-transplant Lymphoproliferative Disorder Interventions: Drug: Rituximab; Drug: Acalabrutinib; Diagnostic Test: CT scans Sponsor: Deepa Jagadeesh Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials